(NYSE: XRX) Company, and leader in transformational customer care
technology, has introduced an intelligent, virtual customer care agent
that can understand, diagnose and solve customer queries in the same way
a human agent would.
By Erin McCarthy
Sarepta Therapeutics Inc. said the U.S. Food and Drug Administration is requiring additional data for the new drug application for its Duchenne muscular dystrophy treatment eteplirsen.
Pain Therapeutics' stock (PTIE) plunged 64% in premarket trade Monday, after Pfizer (PFE) said it would discontinue its agreement to develop and commercialize Pain Therapeutics' Remoxy extended-release treatment for pain.
Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty
pharmaceutical company, today announced that it will release its third
quarter 2014 financial results on Monday, November 10, 2014 and has
scheduled a conference call at 10:00 a.m. EST.
Prudential Retirement Insurance and Annuity Company (PRIAC), a
Prudential Financial, Inc. (PFI) company (NYSE:PRU) has announced that
it will provide reinsurance to UK based insurer Legal & General Group
The Babcock & Wilcox Company (NYSE:BWC) announced today that its
subsidiary, Babcock & Wilcox Power Generation Group, Inc. (B&W PGG), has
been awarded a contract for more than $35 million to design and
manufacture two boilers and air quality control equipment for a power
plant owned by the University of Alaska Fairbanks.
By Chelsey Dulaney
Chiquita Brands International Inc. has agreed to be acquired by a Brazilian orange-juice maker and investment firm, after Chiquita shareholders voted down its planned merger with Irish food company Fyffes PLC on Friday.
By Michael Calia
Valeant Pharmaceuticals International Inc. hinted at the prospect of a higher takeover offer for Botox maker Allergan Inc., which raised its guidance for the year on Monday, as both companies angle for shareholder support ahead of a key deadline.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.